Stock Market & Financial Investment News

Bayer, Regeneron announce regulatory submission of Eylea in JapanRegeneron Pharmaceuticals (REGN) announced that Bayer HealthCare's (BAYRY) Japanese subsidiary, Bayer Yakuhin, has submitted an application for marketing authorization for Eylea Injection for the treatment of patients with diabetic macular edema, or DME, to the Japanese Ministry of Health, Labour and Welfare.